The Covid-19 pandemic has had major implications for clinical rheumatology services. Departments have tried to minimize the spread of the virus by reducing patient attendances, for example by the increased use of telemedicine for the management of stable patients and those conditions deemed non-urgent. This has been largely successful and the practice may well be here to stay. However, US, a service now integral to many rheumatology clinics, cannot be performed remotely and requires close and sometimes prolonged patient contact.
Read the full article here
